Home/Filings/4/0001209191-22-059570
4//SEC Filing

Stimart Tryn 4

Accession 0001209191-22-059570

CIK 0001703057other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 12:22 PM ET

Size

5.5 KB

Accession

0001209191-22-059570

Insider Transaction Report

Form 4
Period: 2022-12-01
Stimart Tryn
Chief Legal Officer
Transactions
  • Award

    Share Options (right to buy)

    2022-12-01+346,9012,658,381 total
    Exercise: $13.18Exp: 2032-12-01Common Shares (346,901 underlying)
Footnotes (1)
  • [F1]The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.

Issuer

AbCellera Biologics Inc.

CIK 0001703057

Entity typeother

Related Parties

1
  • filerCIK 0001834424

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 12:22 PM ET
Size
5.5 KB